University of Antwerp | GenomeWeb

University of Antwerp

Researchers uncovered compound PEX1 or PEX6 mutations in individuals from families affected by a rare condition called Heimler syndrome.

NEW YORK (GenomeWeb) – Researchers affiliated with the University of Antwerp and Antwerp University Hospital have partnered with molecular diagnostics firm Multiplicom to develop a test to help identify individuals at risk for sudden cardiac death.

Aiming to gain a foothold in Europe's emerging next-gen sequencing-based diagnostic market, Multiplicom of Belgium is offering multiplex PCR amplification kits for a range of inherited cancers and other genetic disorders.

Belgian molecular diagnostics firm Multiplicom said this week that it has been awarded €200,000 ($250,000) from the Flemish agency for Innovation by Science and Technology to develop a blood-based non-invasive molecular diagnostic test for fetal aneuploidy.

By Julia Karow
In an effort to unravel the genetics of monogenic forms of epilepsy, a consortium of researchers in Europe has embarked on the Genetics of Rare Epilepsy Syndromes project.

The University of Antwerp spinout's first significant investment will enable it to seek a CE Mark for in vitro diagnostic use of its multiplexed PCR assays for clinical breast cancer and cystic fibrosis sequencing.

CalTech's Peter Bossaerts and colleagues studied whether giving participants equal shares of an invention, and the right to trade them, is better than existing patent models. Bossaerts discussed some of the study's implications for current patent-based economies in a BTW interview.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.